Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript August 8, 2023

Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $0.35.

Operator: Good day, and thank you for standing by. Welcome to the Sangamo Second Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be...